Bitopertin in EPP: Initial Open-Label BEACON Data

Start Date:6/9/2023

Start Time:7:30 AM EDT

Duration:60 minutes

Abstract:

Disc management will be sharing initial data from BEACON, the Phase 2, randomized, open‐label, parallel arm trial of bitopertin in Erythropoietic Protoporphyria (EPP) that is ongoing in Australia.

If you're already registered for the Bitopertin in EPP: Initial Open-Label BEACON Data webcast, click below:

ALREADY REGISTERED?

Speakers

John Quisel, JD, PhD

Chief Executive Officer

Disc Medicine

Will Savage, MD, PhD

Chief Medical Officer

Disc Medicine

First Name
Last Name
Company
Time Zone
Email Address

Already Registered? Technical Requirements System Check Port Troubleshooting